Postmarket Modifications of High-risk Plastic Surgery Devices.
PMID : 32309074 ·
O, l, u, w, a, t, o, b, i, , R, , O, l, a, i, y, a, ;, , D, o, y, i, n, s, o, l, a, , O, y, e, s, i, l, e, ;, , N, i, c, h, o, l, a, s, , S, t, o, n, e, ;, , L, a, w, r, e, n, c, e, , M, b, u, a, g, b, a, w, ;, , M, a, r, k, , H, , M, c, R, a, e
Publicité
Résumé
In the United States, high-risk medical devices must be cleared through the premarket approval (PMA) pathway, which requires clinical evidence ensuring safety and efficacy. Approved devices can be modified and reintroduced to market without additional study through the PMA supplemental review track. This study characterizes the changes of high-risk plastic surgery devices once they undergo initial clearance. A retrospective, cross-sectional analysis of the Food and Drug Administration (FDA) PMA
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.